Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
UKGulf Trade Deal Bahrain Minister Hails Monumental Achievement in Bilateral Relations Foreign Institutional Investors Offload Rs 30000 Crore in Indian Equities in May Total Outflows Reach Rs 222 Lakh Crore Mercury Reaches 52 Billion Valuation in Latest Funding Round Marking 49 Increase Over 14 Months IQVIA Holdings Assessing Wall Street Analysts Outlook After Stock Lags SP 500 Dow Jones Futures Eye Iran Deal Progress Tesla and AI Stocks at Potential Buy Points ACI Worldwide Q1 2026 Earnings Strong EPS Beat Powered by Operational Efficiency Pixelworks Q1 2026 Earnings Stunning EPS Beat Overshadowed by Revenue Ambiguity MasTec MTZ Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline MDLZ Q1 2026 Earnings Strong EPS Beat Amidst Cost Discipline Sylvamo Corporation SLVM Holds Steady Near Support as Trading Volume Modulates American Financial Group AFG Holds Steady Near Support as Consolidation Continues Formula Systems FORTY Faces Steep Decline as Shares Test Key Support Levels PS International Group Ltd PSIG Advances 183 Testing Key Resistance at 820 OpenAIs Potential IPO Poised to Be RecordBreaking Challenged Only by SpaceX Pharmaceutical Sector on Alert as Ebola Outbreak Gathers Pace Trump Administration Proposes GovernmentWide Nondisclosure Agreements for Federal Workers QLine Biotech IPO Allotment Finalized Today Grey Market Premium at 115 Cybersecurity Jobs Surge 11 in Q1 Amid AIDriven Demand Berkshire Hathaway Reenters Airlines with 26 Billion Stake in Delta Air Lines Dow Edges Higher as AI Momentum Cools Oil Slips on USIran Talks Progress Lenovo Shares Surge Nearly 20 as AI Revenue Nearly Doubles Driving Record Earnings Prediction Markets Face Escalating Legal Challenges from State Regulators Traders Bet on IonQ Micron and Anduril as Next Potential US Government Stake Targets